Project | PrIMAVeRa

top of page

Project
Structure
Governance
Consortium
Publications
News
Contact
More

Use tab to navigate through the menu items.

Vaccine

About PrIMAVeRa

What is PrIMAVeRa?

Why is PrIMAVeRa needed?

What is PrIMAVeRa’s expected impact?

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034420. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This communication reflects the authors' view(s) and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

Name

Institution

Email

Thanks for submitting! You can unsubscribe at anytime.

Privacy Policy | Disclaimer | Contact us | Back to top

© 2024 European Vaccine Initiative. Designed by European Vaccine Initiative

bottom of page